Clarivate (NYSE: CLVT) president receives 377,358-share stock grant

Rhea-AI Filing Summary

Mourad Maroun S. reported acquisition or exercise transactions in this Form 4 filing.

Clarivate PLC executive Mourad Maroun S., President, IP, received a grant of 377,358 Ordinary Shares as a stock award at no cost. Following this award, his direct holdings increased to 916,926 Ordinary Shares. The filing also shows 105,000 Ordinary Shares held indirectly through his spouse.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Mourad Maroun S.

Role President, IP

Type	Security	Shares	Price	Value
Grant/Award	Ordinary Shares	377,358	$0.00	--
holding	Ordinary Shares	--	--	--

Holdings After Transaction: Ordinary Shares — 916,926 shares (Direct); Ordinary Shares — 105,000 shares (Indirect, By spouse)

Footnotes (1)

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Mourad Maroun S.

(Last) (First) (Middle)

C/O CLARIVATE PLC

70 ST. MARY AXE

(Street)

LONDON X0 EC3A 8BE

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CLARIVATE PLC [ CLVT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President, IP

3. Date of Earliest Transaction (Month/Day/Year)
03/15/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	03/15/2026		A		377,358	A	$0	916,926	D
Ordinary Shares								105,000	I	By spouse

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/ John Doulamis, Attorney-in-Fact	03/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Clarivate (CLVT) report for Mourad Maroun S.?

Clarivate reported that President, IP, Mourad Maroun S. received a grant of 377,358 Ordinary Shares. The award was recorded at a price of $0.00 per share, indicating it is a compensation-related stock grant rather than an open-market purchase.

How many Clarivate shares does Mourad Maroun S. hold after this Form 4?

After the reported grant, Mourad Maroun S. directly holds 916,926 Ordinary Shares. The filing also discloses an additional 105,000 Ordinary Shares held indirectly through his spouse, highlighting both his direct and family-related economic exposure to Clarivate stock.

Was the Clarivate Form 4 transaction a stock purchase or a grant?

The transaction was a grant or award acquisition, not a market purchase. The Form 4 labels the code as an "A" transaction, meaning a stock grant, with 377,358 Ordinary Shares awarded at a stated price of $0.00 per share to the reporting executive.

Does Mourad Maroun S. have indirect ownership of Clarivate (CLVT) shares?

Yes. In addition to his direct holdings, the Form 4 shows 105,000 Ordinary Shares held indirectly "By spouse." This indicates additional beneficial exposure to Clarivate equity through a related party, separate from his directly owned shares.

What role does the insider in this Clarivate Form 4 hold at the company?

The reporting person, Mourad Maroun S., serves as Clarivate’s President, IP. His senior executive role and the large stock grant of 377,358 Ordinary Shares indicate the transaction is part of his compensation package rather than routine trading activity.